Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functions

Infection and Immunity

Volumn 77, Issue 8, 2009, Pages 3272-3283

  Liu, Dong ^a   Kebaier, Chahnaz ^b   Pakpour, Nazzy ^b   Capul, Althea A ^c   Beverley, Stephen M ^c   Scott, Phillip ^b   Uzonna, Jude E ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; GLYCAN DERIVATIVE; INTERLEUKIN 12P40; INTERLEUKIN 2; LIPOPHOSPHOGLYCAN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHOSPHOGLYCAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CELL FUNCTION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HOST RESISTANCE; IMMUNE RESPONSE; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; CYTOKINES; DENDRITIC CELLS; FEMALE; GLYCOSPHINGOLIPIDS; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOLOGIC FACTORS; INTERLEUKIN-12 SUBUNIT P40; LEISHMANIA MAJOR; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; POLYSACCHARIDES; PROTOZOAN PROTEINS; T-LYMPHOCYTES;

EID: 67651207725     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01447-08     Document Type: Article

References (55)

1. Aebischer, T., C. L. Bennett, M. Pelizzola, C. Vizzardelli, N. Pavelka, M. Urbano, M. Capozzoli, A. Luchini, T. Ilg, F. Granucci, C. C. Blackburn, and P. Ricciardi-Castagnoli. 2005. A critical role for lipophosphoglycan in proin-flammatory responses of dendritic cells to Leishmania mexicana. Eur. J. Immunol. 35:476-486.
2. Antunez, M. I., and R. L. Cardoni. 2001. Early IFN-gamma production is related to the presence of interleukin (IL)-18 and the absence of IL-13 in experimental Trypanosoma cruzi infections. Immunol. Lett. 79:189-196.
3. Ato, M., A. Maroof, S. Zubairi, H. Nakano, T. Kakiuchi, and P. M. Kaye. 2006. Loss of dendritic cell migration and impaired resistance to Leishmania donovani infection in mice deficient in CCL19 and CCL21. J. Immunol. 176:5486-5493.
4. Baldwin, T., S. Henri, J. Curtis, M. O'Keeffe, D. Vremec, K. Shortman, and E. Handman. 2004. Dendritic cell populations in Leishmania major-infected skin and draining lymph nodes. Infect. Immun. 72:1991-2001.
5. Belkaid, Y., E. Von Stebut, S. Mendez, R. Lira, E. Caler, S. Bertholet, M. C. Udey, and D. Sacks. 2002. CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J. Immunol. 168:3992-4000.
6. Beverley, S. M., and S. J. Turco. 1998. Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania. Trends Microbiol. 6:35-40.
7. Capul, A. A., T. Barron, D. E. Dobson, S. J. Turco, and S. M. Beverley. 2007. Two functionally divergent UDP-Gal nucleotide sugar transporters participate in phosphoglycan synthesis in Leishmania major. J. Biol. Chem. 282: 14006-14017.
8. Capul, A. A., S. Hickerson, T. Barron, S. J. Turco, and S. M. Beverley. 2007. Comparisons of mutants lacking the Golgi UDP-galactose or GDP-mannose transporters establish that phosphoglycans are important for promastigote but not amastigote virulence in Leishmania major. Infect. Immun. 75:4629-4637.
9. Courret, N., E. Prina, E. Mougneau, E. M. Saraiva, D. L. Sacks, N. Glaichenhaus, and J. C. Antoine. 1999. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites. Eur. J. Immunol. 29:762-773.
10. Cunningham, A. C. 2002. Parasitic adaptive mechanisms in infection by leishmania. Exp. Mol. Pathol. 72:132-141.
11. Descoteaux, A., and S. J. Turco. 1999. Glycoconjugates in Leishmania infectivity. Biochim. Biophys. Acta 1455:341-352.
12. Desjardins, M., and A. Descoteaux. 1997. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J. Exp. Med. 185:2061-2068.
13. Desjardins, M., and A. Descoteaux. 1998. Survival strategies of Leishmania donovani in mammalian host macrophages. Res. Immunol. 149:689-692.
14. Desjeux, P. 2004. Leishmaniasis. Nat. Rev. Microbiol. 2:692.
15. Desjeux, P. 2004. Leishmaniasis: current situation and new perspectives. Comp. Immunol. Microbiol. Infect. Dis. 27:305-318.
16. Ghosh, M., and S. Bandyopadhyay. 2004. Interaction of Leishmania parasites with dendritic cells and its functional consequences. Immunobiology 209:173-177.
17. Hensler, H. R., G. Rappocciolo, C. R. Rinaldo, and F. J. Jenkins. 2009. Cytokine production by human herpesvirus 8-infected dendritic cells. J. Gen. Virol. 90:79-83.
18. Huang, C., and S. J. Turco. 1993. Defective galactofuranose addition in lipophosphoglycan biosynthesis in a mutant of Leishmania donovani. J. Biol. Chem. 268:24060-24066.
19. Iezzi, G., A. Frohlich, B. Ernst, F. Ampenberger, S. Saeland, N. Glaichenhaus, and M. Kopf. 2006. Lymph node resident rather than skin-derived dendritic cells initiate specific T cell responses after Leishmania major infection. J. Immunol. 177:1250-1256.
20. Ilg, T., M. Demar, and D. Harbecke. 2001. Phosphoglycan repeat-deficient Leishmania mexicana parasites remain infectious to macrophages and mice. J. Biol. Chem. 276:4988-4997.
21. Ilg, T., E. Handman, and Y. D. Stierhof. 1999. Proteophosphoglycans from Leishmania promastigotes and amastigotes. Biochem. Soc. Trans. 27:518-525.
22. + T cells which react to the Leishmania major LACK antigen rapidly secrete interleukin-4 and are detrimental to the host in resistant B10.D2 mice. Infect. Immun. 67:3641-3644.
23. Julia, V., M. Rassoulzadegan, and N. Glaichenhaus. 1996. Resistance to Leishmania major induced by tolerance to a single antigen. Science 274:421-423.
24. Konecny, P., A. J. Stagg, H. Jebbari, N. English, R. N. Davidson, and S. C. Knight. 1999. Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro. Eur. J. Immunol. 29:1803-1811.
25. Launois, P., I. Maillard, S. Pingel, K. G. Swihart, I. Xenarios, H. Acha-Orbea, H. Diggelmann, R. M. Locksley, H. R. MacDonald, and J. A. Louis. 1997. IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6:541-549.
26. Lyons, A. B., and C. R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171:131-137.
27. Ma, D., D. G. Russell, S. M. Beverley, and S. J. Turco. 1997. Golgi GDP-mannose uptake requires Leishmania LPG2. A member of a eukaryotic family of putative nucleotide-sugar transporters. J. Biol. Chem. 272:3799-3805.
28. Malherbe, L., C. Filippi, V. Julia, G. Foucras, M. Moro, H. Appel, K. Wucherpfennig, J. C. Guery, and N. Glaichenhaus. 2000. Selective activation and expansion of high-affinity CD4+ T cells in resistant mice upon infection with Leishmania major. Immunity 13:771-782.
29. McDowell, M. A., M. Marovich, R. Lira, M. Braun, and D. Sacks. 2002. Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent. Infect. Immun. 70:3994-4001.
30. McDowell, M. A., and D. L. Sacks. 1999. Inhibition of host cell signal transduction by Leishmania: observations relevant to the selective impairment of IL-12 responses. Curr. Opin. Microbiol. 2:438-443.
31. Moser, M., and K. M. Murphy. 2000. Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 1:199-205.
32. O'Garra, A., and K. Murphy. 1994. Role of cytokines in determining Tlymphocyte function. Curr. Opin. Immunol. 6:458-466.
33. Olivier, M., D. J. Gregory, and G. Forget. 2005. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin. Microbiol. Rev. 18:293-305.
34. Park, A. Y., and P. Scott. 2001. Il-12: keeping cell-mediated immunity alive. Scand. J. Immunol. 53:529-532.
35. Piedrafita, D., L. Proudfoot, A. V. Nikolaev, D. Xu, W. Sands, G. J. Feng, E. Thomas, J. Brewer, M. A. Ferguson, J. Alexander, and F. Y. Liew. 1999. Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans. Eur. J. Immunol. 29:235-244.
36. Ponte-Sucre, A., D. Heise, and H. Moll. 2001. Leishmania major lipophosphoglycan modulates the phenotype and inhibits migration of murine Langerhans cells. Immunology 104:462-467.
37. Poulter, L. W., and C. R. Pandolph. 1982. Mechanisms of immunity to leishmaniasis. IV. Significance of lymphatic drainage from the site of infection. Clin. Exp. Immunol. 48:396-402.
38. Prina, E., T. Lang, N. Glaichenhaus, and J. C. Antoine. 1996. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages. J. Immunol. 156:4318-4327.
39. Reiner, S. L., D. J. Fowell, N. H. Moskowitz, K. Swier, D. R. Brown, C. R. Brown, C. W. Turck, P. A. Scott, N. Killeen, and R. M. Locksley. 1998. Control of Leishmania major by a monoclonal alpha beta T cell repertoire. J. Immunol. 160:884-889.
40. Ritter, U., A. Meissner, C. Scheidig, and H. Korner. 2004. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. Eur. J. Immunol. 34:1542-1550.
41. Scott, P., and C. A. Hunter. 2002. Dendritic cells and immunity to leishmaniasis and toxoplasmosis. Curr. Opin. Immunol. 14:466-470.
42. Scott, P., E. Pearce, P. Natovitz, and A. Sher. 1987. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. J. Immunol. 139:221-227.
43. Spath, G. F., L. Epstein, B. Leader, S. M. Singer, H. A. Avila, S. J. Turco, and S. M. Beverley. 2000. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc. Natl. Acad. Sci. USA 97:9258-9263.
44. Spath, G. F., L. A. Garraway, S. J. Turco, and S. M. Beverley. 2003. The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proc. Natl. Acad. Sci. USA 100:9536-9541.
45. Spath, G. F., L. F. Lye, H. Segawa, D. L. Sacks, S. J. Turco, and S. M. Beverley. 2003. Persistence without pathology in phosphoglycan-deficient Leishmania major. Science 301:1241-1243.
46. Stetson, D. B., M. Mohrs, V. Mallet-Designe, L. Teyton, and R. M. Locksley. 2002. Rapid expansion and IL-4 expression by Leishmania-specific naive helper T cells in vivo. Immunity 17:191-200.
47. Sundar, S. 2001. Drug resistance in Indian visceral leishmaniasis. Trop. Med. Int. Health 6:849-854.
48. Sundar, S., and M. Rai. 2002. Advances in the treatment of leishmaniasis. Curr. Opin. Infect. Dis. 15:593-598.
49. Turco, S. J., and A. Descoteaux. 1992. The lipophosphoglycan of Leishmania parasites. Annu. Rev. Microbiol. 46:65-94.
50. Turco, S. J., G. F. Spath, and S. M. Beverley. 2001. Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species. Trends Parasitol. 17:223-226.
51. Uzonna, J. E., G. F. Spath, S. M. Beverley, and P. Scott. 2004. Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response. J. Immunol. 172:3793-3797.
52. Wang, Q., L. Malherbe, D. Zhang, K. Zingler, N. Glaichenhaus, and N. Killeen. 2001. CD4 promotes breadth in the TCR repertoire. J. Immunol. 167:4311-4320.
53. Wang, Z. E., S. Zheng, D. B. Corry, D. K. Dalton, R. A. Seder, S. L. Reiner, and R. M. Locksley. 1994. Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc. Natl. Acad. Sci. USA 91:12932-12936.
54. Zaph, C., J. Uzonna, S. M. Beverley, and P. Scott. 2004. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat. Med. 10:1104-1110.
55. Zufferey, R., S. Allen, T. Barron, D. R. Sullivan, P. W. Denny, I. C. Almeida, D. F. Smith, S. J. Turco, M. A. Ferguson, and S. M. Beverley. 2003. Ether phospholipids and glycosylinositolphospholipids are not required for amastigote virulence or for inhibition of macrophage activation by Leishmania major. J. Biol. Chem. 278:44708-44718.